Zepbound users lose an average of 15% to 20.9% of body weight over 72 weeks, based on the SURMOUNT-1 trial, with the highest dose reaching up to 22.5% in patients who stayed on it through the full protocol. That average excludes what happens if you stall out on a lower dose, skip weeks, or don't adjust eating and activity as the appetite suppression kicks in — patients who do those things typically land well below the top-line number.
- Zepbound users lost 15% to 20.9% of body weight on average over 72 weeks in the SURMOUNT-1 trial.
- The 15mg dose reached up to 22.5% loss in patients who completed the full protocol.
- Placebo patients lost only 3.1% in the same trial, isolating the drug's actual effect.
- Dose reached, adherence, and diet quality drive the gap between the low and high end of results.
- GoodLife Health prescribes branded Zepbound at pharmacy cost, with no markup added to the medication.
Why this matters
Zepbound is the brand name for tirzepatide, a medication that activates both the GIP and GLP-1 receptors, not just GLP-1 like semaglutide-based drugs. That dual action is why its trial numbers run higher than earlier GLP-1-only medications, and why it's become the reference point for how much weight loss is realistically possible on an FDA-approved drug in 2026.
The 15% to 20.9% range comes from averaging an entire trial population, which means half the people in SURMOUNT-1 landed above it and half landed below.
Weight loss on any GLP-1 or dual agonist is a system-level response — appetite, insulin sensitivity, and inflammation markers move together, which is the same reason a clinician tracking labs alongside the scale gets a fuller picture than the number alone.
GoodLife Health treats that response as one interconnected system rather than a weight number in isolation, pairing medication with quarterly lab work so dose changes are based on data, not guesswork.
The number that doesn't show up in most headlines is what it costs to sustain a dose long enough to see it. The Zepbound cost without insurance breakdown matters here because patients who bounce between doses or stop early for cost reasons are the ones who land at the bottom of the range, not the top.
How much weight can you lose on Zepbound
The answer depends almost entirely on which maintenance dose you reach and how long you stay on it. SURMOUNT-1 tracked patients across three dose levels for 72 weeks, and the gap between the lowest and highest dose is nearly six percentage points of body weight.
Zepbound dose comparison (SURMOUNT-1, 72 weeks)
| Dose | Average weight loss (72 weeks) | Best for |
|---|---|---|
| 5 mg | 15.0% | Early titration or patients sensitive to GI side effects |
| 10 mg | 19.5% | Most patients at a typical maintenance dose |
| 15 mg | 20.9% (up to 22.5% in completers) | Patients who tolerate titration well and want the largest effect |
The placebo group in the same trial lost 3.1% on diet and lifestyle counseling alone. That gap is the actual drug effect — roughly six to seven times the placebo result at the 15 mg dose — and it's the number worth repeating when someone claims the results are "just diet."
Zepbound 5 mg: 15% average weight loss
Five milligrams is where most patients start their maintenance phase after the initial titration weeks, and it's also where some patients choose to stay if higher doses bring on nausea or fatigue that outweighs the extra loss. A 15% average is still a meaningful clinical result for someone starting at 220 pounds — roughly 33 pounds over 72 weeks — but it's the floor of what Zepbound delivers in trial data, not the ceiling.
Patients who plateau at 5 mg and want more should talk to their clinician about titrating up rather than assuming the drug has stopped working. Verdict: solid starting point, not the dose to judge the drug's ceiling by.
Zepbound 10 mg: 19.5% average weight loss
Ten milligrams is the dose most SURMOUNT-1 patients ended up on for the bulk of the trial, and it's where the loss curve starts closing in on the top-dose numbers without the highest rate of GI side effects. Nearly one in five pounds of starting body weight came off at this dose on average.
This is the dose where the gap between "average" and "individual" widens the most — patients combining it with resistance training and adequate protein intake tend to outperform the trial average, while those relying on the drug alone without dietary changes tend to underperform it. Verdict: the middle-ground dose most patients settle into, and a reasonable target if 15 mg side effects are a concern.
Zepbound 15 mg: 20.9% average weight loss (up to 22.5% in completers)
Fifteen milligrams is the highest FDA-approved maintenance dose and the one behind Zepbound's headline numbers. The 20.9% figure is the intention-to-treat average across everyone assigned to that dose; the 22.5% figure is the per-protocol result among patients who completed the full 72 weeks on schedule — the gap between those two numbers is basically the cost of missed doses and early dropouts.
That gap is the actual drug effect — roughly six to seven times the placebo result at the 15 mg dose — and it's the number worth repeating when someone claims the results are "just diet."
Reaching 15 mg requires working through the full titration schedule, which how Zepbound dosing escalates week by week covers in more detail — it typically takes several months to get there safely, not a few weeks. Verdict: the strongest documented result available, but only if you actually stay on schedule long enough to reach and hold it.
Why weight loss on Zepbound varies
The 15% to 22.5% range isn't random — it tracks a handful of identifiable factors, most of which are within a patient's control once they're on the medication.
- Dose reached and time held there. Every jump from 5 mg to 15 mg adds several percentage points of average loss in trial data.
- Adherence to the weekly schedule. Missed or delayed doses reset momentum and are one of the biggest drivers of underperforming the trial average.
- Starting body composition. Patients with more weight to lose tend to lose more in absolute pounds, though percentage results cluster closer to the ranges above.
- Diet quality and protein intake. Appetite suppression cuts calorie intake automatically, but low protein intake accelerates muscle loss alongside fat loss.
- Resistance training. Patients who lift weights during treatment tend to preserve more lean mass, which changes how the loss looks on a scale versus a DEXA scan.
- Whether dose changes are guided by labs. Adjusting dose based on how someone is actually responding, rather than a fixed schedule regardless of side effects, tends to keep patients on the medication longer.
Is Zepbound stronger than Ozempic for weight loss?
Zepbound (tirzepatide) produced larger average weight loss than Ozempic's active ingredient in separate trials — up to 22.5% in SURMOUNT-1 versus roughly 15% for semaglutide in the STEP-1 trial. These weren't head-to-head trials run on the same patient population at the same time, so the comparison is cross-trial, not a direct test, but the gap has held up consistently enough that it's the standard talking point clinicians use when patients ask which drug to start with.
Ozempic is also FDA-approved specifically for type 2 diabetes, with Wegovy as semaglutide's weight-management-approved counterpart — the same distinction that separates Mounjaro (diabetes) from Zepbound (weight management) on the tirzepatide side.
How long does it take to see results on Zepbound?
Most patients notice reduced appetite within the first few weeks, well before any of the 72-week averages apply. The 15% to 20.9% numbers reflect a full year and a half on the medication, working through titration and holding at a maintenance dose — not a quick result measured in weeks.
Expecting SURMOUNT-1-level results by month two sets patients up to think the drug isn't working when it's actually still in the titration phase. Weight loss on Zepbound is a curve that steepens once a therapeutic dose (10 mg or 15 mg) is reached and held, typically several months in.
Do you gain weight back after stopping Zepbound?
Yes — trial data on stopping tirzepatide shows meaningful regain within a year for patients who discontinue without a maintenance plan. In the SURMOUNT-4 trial, patients switched from tirzepatide to placebo after 36 weeks regained a substantial share of the weight they'd lost over the following year, while patients who stayed on the medication continued losing.
This is the reason clinicians frame GLP-1/GIP therapy as a chronic-disease treatment rather than a course that ends once a goal weight is hit — the biology driving appetite and weight regulation doesn't change just because the medication stops.
FAQ
How much weight can you lose on Zepbound in the first 3 months?
Most patients are still titrating during the first 3 months, so weight loss trails the 72-week trial averages of 15% to 20.9%. Visible results build once a maintenance dose of 10mg or 15mg is reached and held.
Is Zepbound stronger than Ozempic?
Tirzepatide (Zepbound) produced larger average weight loss than semaglutide in separate trials, up to 22.5% in SURMOUNT-1 versus roughly 15% in STEP-1. The two drugs were never tested head-to-head in the same trial, so this is a cross-trial comparison, not a direct one.
What is the maximum Zepbound dose?
15mg weekly is the highest FDA-approved maintenance dose of Zepbound, reached through a titration schedule that starts at a much lower dose and increases every few weeks.
Is Zepbound the same as Mounjaro?
Zepbound and Mounjaro both contain tirzepatide, the same molecule. Mounjaro is FDA-approved for type 2 diabetes, Zepbound for weight management, and cash-pay weight-loss patients are typically routed to Zepbound.
Do you gain weight back after stopping Zepbound?
Yes, SURMOUNT-4 trial data show patients who switched from tirzepatide to placebo after 36 weeks regained a large share of the weight lost over the following year, while patients who stayed on the drug kept losing.
Does insurance cover Zepbound for weight loss?
Coverage varies by plan, and many insurers require a documented BMI threshold or specific diagnosis before approving it. A clinician can submit prior authorization, but approval isn't guaranteed across plans.
How long does it take to see results on Zepbound?
Appetite changes often start within the first few weeks, but the trial-reported averages of 15% to 20.9% weight loss reflect a full 72 weeks on the medication, not a fast result.
How much weight can you realistically lose on Zepbound in a year?
Most patients land between 15% and 21% of body weight by 72 weeks based on SURMOUNT-1 averages, skewing toward the higher end for those who reach and hold the 15mg dose.
One last thing
The number that gets buried in most Zepbound coverage isn't the 22.5% headline — it's the 3.1% placebo result sitting next to it in the same 72-week trial. That comparison is the entire case for a dual GIP/GLP-1 drug over diet and exercise counseling alone: roughly six to seven times more weight loss at the top dose, in the same population, over the same time frame. In 2026, that gap is still the strongest evidence available for what Zepbound actually does versus what a structured diet program does on its own.
Related guides
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/